Literature DB >> 19492140

Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes.

Andrew C Newby1, Sarah J George, Yasmin Ismail, Jason L Johnson, Graciela B Sala-Newby, Anita C Thomas.   

Abstract

Plaque rupture underlies most myocardial infarctions. Plaques vulnerable to rupture have thin fibrous caps, an excess of macrophages over vascular smooth muscle cells, large lipid cores, and depletion of collagen and other matrix proteins form the cap and lipid core. Production of matrix metalloproteinases from macrophages is prominent in human plaques, and studies in genetically modified mice imply a causative role for metalloproteinases in plaque vulnerability. Recent in-vitro studies on human monocyte-derived macrophages and on foam-cell macrophages generated in vivo suggest the existence of several macrophage phenotypes with distinct patterns of metalloproteinase expression. These phenotypes could play differing roles in cap, core and aneurysm formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19492140      PMCID: PMC2850555     

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  38 in total

1.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.

Authors:  Koichi Shimizu; Masayoshi Shichiri; Peter Libby; Richard T Lee; Richard N Mitchell
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

2.  Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation.

Authors:  J Silence; F Lupu; D Collen; H R Lijnen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

3.  Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo.

Authors:  Alexander J Chase; Mark Bond; Martin F Crook; Andrew C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

4.  ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis.

Authors:  V Lemaître; T K O'Byrne; A C Borczuk; Y Okada; A R Tall; J D'Armiento
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

5.  Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene.

Authors:  J Silence; D Collen; H R Lijnen
Journal:  Circ Res       Date:  2002-05-03       Impact factor: 17.367

6.  Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.

Authors:  M Crisby; G Nordin-Fredriksson; P K Shah; J Yano; J Zhu; J Nilsson
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

7.  Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1.

Authors:  Vincent Lemaître; Paul D Soloway; Jeanine D'Armiento
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

8.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

9.  Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.

Authors:  Aernout Luttun; Esther Lutgens; Ann Manderveld; Katleen Maris; Désiré Collen; Peter Carmeliet; Lieve Moons
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Authors:  K Brand; S Page; G Rogler; A Bartsch; R Brandl; R Knuechel; M Page; C Kaltschmidt; P A Baeuerle; D Neumeier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

View more
  49 in total

Review 1.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

2.  Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.

Authors:  Jie Hong Hu; Liang Du; Talyn Chu; Goro Otsuka; Nagadhara Dronadula; Mia Jaffe; Sean E Gill; William C Parks; David A Dichek
Journal:  Circulation       Date:  2010-03-29       Impact factor: 29.690

Review 3.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

4.  Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Saravanan Subramanian; Devendra K Agrawal
Journal:  Atherosclerosis       Date:  2016-03-19       Impact factor: 5.162

5.  Pentosan polysulfate inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbits: differential modulation of metalloproteinase-2 and -9.

Authors:  Enrico Lupia; Feng Zheng; Fabrizio Grosjean; Ivan Tack; Sophie Doublier; Sharon J Elliot; Helen Vlassara; Gary E Striker
Journal:  Lab Invest       Date:  2011-10-31       Impact factor: 5.662

6.  Inhibition of inositol monophosphatase by lithium chloride induces selective macrophage apoptosis in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Cor E Van Hove; Dorien M Schrijvers; Vicky Y Hoymans; Luc Van Vaeck; Paul Fransen; Hidde Bult; Guido R Y De Meyer
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

7.  Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.

Authors:  Gustavo Bonacci; Francisco J Schopfer; Carlos I Batthyany; Tanja K Rudolph; Volker Rudolph; Nicholas K H Khoo; Eric E Kelley; Bruce A Freeman
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

8.  Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Devendra K Agrawal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

9.  TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

Authors:  Minako Ishibashi; Scott Sayers; Jeanine M D'Armiento; Alan R Tall; Carrie L Welch
Journal:  Atherosclerosis       Date:  2013-04-09       Impact factor: 5.162

10.  Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: tissue microarray detection of collagen I, collagen III and elastin levels.

Authors:  Chee Hoe Kong; Xiao Yun Lin; Chin Cheng Woo; Hung Chew Wong; Chuen Neng Lee; A Mark Richards; Vitaly A Sorokin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.